Drug Approval | October 18, 2023
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Alignment of carbon-fiber can be controlled during the 3D printing process
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
Subscribe To Our Newsletter & Stay Updated
